Comparing DIAGNOS (OTCMKTS:DGNOF) & L’Oreal (OTC:LRLCY)

DIAGNOS (OTCMKTS:DGNOF) and L’Oreal (OTC:LRLCY) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for DIAGNOS and L’Oreal, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DIAGNOS	0	0	0	0	0.00
L’Oreal	0	1	0	0	2.00

Earnings and Valuation

This table compares DIAGNOS and L’Oreal”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DIAGNOS	$130,000.00	111.27	-$2.31 million	($0.04)	-3.55
L’Oreal	$47.06 billion	4.83	$6.94 billion	N/A	N/A

L’Oreal has higher revenue and earnings than DIAGNOS.

Risk and Volatility

DIAGNOS has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, L’Oreal has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500.

Institutional & Insider Ownership

0.4% of L’Oreal shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares DIAGNOS and L’Oreal’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DIAGNOS	-2,912.77%	N/A	-242.73%
L’Oreal	N/A	N/A	N/A

Summary

L’Oreal beats DIAGNOS on 7 of the 8 factors compared between the two stocks.

About DIAGNOS

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

About L’Oreal

At L’Or?al, they have made cosmetics the focus of all their energy and know-how for nearly a century. They are fully committed to putting their expertise and research resources to work for the well-being of men and women, in all their diversity, around the world.